Certain Options of Edgewise Therapeutics, Inc. are subject to a Lock-Up Agreement Ending on 22-SEP-2021. These Options will be under lockup for 181 days starting from 25-MAR-2021 to 22-SEP-2021.

Details:
Executive officers, directors and the holders of substantially all of capital stock and securities convertible into or exchangeable for company's capital stock have entered into market stand-off agreements with issuer and lock-up agreements with the underwriters under which they have agreed, subject to specific exceptions described in the section titled “Underwriting,” not to sell, directly or indirectly, any shares of common stock without the permission of the underwriters for a period of 180 days following the date of this prospectus.